Insider Transactions in Q2 2023 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2023
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
212
-2.71%
|
$50,880
$240.0 P/Share
|
|
May 19
2023
|
Paul R Kirchgraber CEO, Covance Drug Development |
SELL
Open market or private sale
|
Direct |
4,300
-24.93%
|
$928,800
$216.91 P/Share
|
|
May 19
2023
|
Paul R Kirchgraber CEO, Covance Drug Development |
BUY
Exercise of conversion of derivative security
|
Direct |
4,300
+19.96%
|
$782,600
$182.51 P/Share
|
|
May 18
2023
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Open market or private sale
|
Direct |
1,500
-18.32%
|
$324,000
$216.77 P/Share
|
|
May 18
2023
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+15.48%
|
$195,000
$130.6 P/Share
|